v3.24.4
INCOME TAXES - Schedule of Components of Company's Deferred Income Tax Assets and Liabilities (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Deferred tax assets:    
Net operating loss carryforward $ 13,095,540 $ 9,469,767
Research and development credits 1,647,502 1,229,181
Capitalized pre-business expenses 2,229,904 2,563,946
Accrued expenses 124,458 26,290
Stock-based compensation 899,453 481,062
Inventory reserve 243,070 64,726
Operating lease liability 127,116 158,388
Capitalized 174 research and development costs 1,905,522 919,466
Total deferred tax assets before valuation allowance 20,272,565 14,912,826
Less valuation allowance (19,756,671) (14,506,698)
Total deferred tax assets 515,894 406,128
Deferred tax liabilities    
Fixed assets (390,191) (264,377)
Right-of-use assets (125,703) (141,751)
Total deferred tax liabilities (515,894) (406,128)
Net deferred tax asset (liability) $ 0 $ 0